These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34680138)

  • 1. Sertoli Cells Improve Myogenic Differentiation, Reduce Fibrogenic Markers, and Induce Utrophin Expression in Human DMD Myoblasts.
    Salvadori L; Chiappalupi S; Arato I; Mancuso F; Calvitti M; Marchetti MC; Riuzzi F; Calafiore R; Luca G; Sorci G
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice.
    Chiappalupi S; Luca G; Mancuso F; Madaro L; Fallarino F; Nicoletti C; Calvitti M; Arato I; Falabella G; Salvadori L; Di Meo A; Bufalari A; Giovagnoli S; Calafiore R; Donato R; Sorci G
    Biomaterials; 2016 Jan; 75():313-326. PubMed ID: 26523508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and neuregulin-1 as regulators of utrophin expression via the activation of NRG-1/ErbB signaling pathway in mdx cells.
    Juretić N; Díaz J; Romero F; González G; Jaimovich E; Riveros N
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):770-780. PubMed ID: 27988307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. sPIF promotes myoblast differentiation and utrophin expression while inhibiting fibrosis in Duchenne muscular dystrophy via the H19/miR-675/let-7 and miR-21 pathways.
    Morgoulis D; Berenstein P; Cazacu S; Kazimirsky G; Dori A; Barnea ER; Brodie C
    Cell Death Dis; 2019 Jan; 10(2):82. PubMed ID: 30692507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.
    Sohn J; Lu A; Tang Y; Wang B; Huard J
    Hum Mol Genet; 2015 Jul; 24(13):3814-29. PubMed ID: 25859011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
    Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
    Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
    Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity.
    Hardee JP; Martins KJB; Miotto PM; Ryall JG; Gehrig SM; Reljic B; Naim T; Chung JD; Trieu J; Swiderski K; Philp AM; Philp A; Watt MJ; Stroud DA; Koopman R; Steinberg GR; Lynch GS
    Mol Metab; 2021 Mar; 45():101157. PubMed ID: 33359740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice.
    Freeman E; Langlois S; Leyba MF; Ammar T; Léger Z; McMillan HJ; Renaud JM; Jasmin BJ; Cowan KN
    Skelet Muscle; 2024 Apr; 14(1):8. PubMed ID: 38671506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy.
    Perkins KJ; Davies KE
    FEBS Lett; 2018 Jun; 592(11):1856-1869. PubMed ID: 29772070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.
    Domenig SA; Bundschuh N; Lenardič A; Ghosh A; Kim I; Qabrati X; D'Hulst G; Bar-Nur O
    Stem Cell Reports; 2022 Feb; 17(2):321-336. PubMed ID: 34995499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts.
    Gosselin MRF; Mournetas V; Borczyk M; Verma S; Occhipinti A; Róg J; Bozycki L; Korostynski M; Robson SC; Angione C; Pinset C; Gorecki DC
    Elife; 2022 Sep; 11():. PubMed ID: 36164827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening.
    Soblechero-Martín P; Albiasu-Arteta E; Anton-Martinez A; de la Puente-Ovejero L; Garcia-Jimenez I; González-Iglesias G; Larrañaga-Aiestaran I; López-Martínez A; Poyatos-García J; Ruiz-Del-Yerro E; Gonzalez F; Arechavala-Gomeza V
    Sci Rep; 2021 Sep; 11(1):18188. PubMed ID: 34521928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
    Miura P; Jasmin BJ
    Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-generation compound for the modulation of utrophin in the therapy of DMD.
    Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE
    Hum Mol Genet; 2015 Aug; 24(15):4212-24. PubMed ID: 25935002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy?
    Chiappalupi S; Salvadori L; Luca G; Riuzzi F; Calafiore R; Donato R; Sorci G
    Cell Prolif; 2019 May; 52(3):e12599. PubMed ID: 30912260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1/2 inhibition.
    Gleneadie HJ; Fernandez-Ruiz B; Sardini A; Van de Pette M; Dimond A; Prinjha RK; McGinty J; French PMW; Bagci H; Merkenschlager M; Fisher AG
    Commun Biol; 2023 Mar; 6(1):318. PubMed ID: 36966198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.